E. Allen

发表

The use of variance components for the assessment of outcome measures in rheumatology

V. Farewell, E. Allen, 2011 .

Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients

I. Bruce, D. Gladman, E. Ginzler, 2017, Arthritis care & research.

Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity.

I. Bruce, C. Gordon, D. Isenberg, 2006, Arthritis and rheumatism.

Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years.

D. Isenberg, Anisur Rahman, E. Allen, 2009, Rheumatology.

Development and initial validation of an updated version of the British Isles Lupus Assessment Group ’ s disease activity index for patients with systemic lupus erythematosus

I. Bruce, C. Gordon, D. Isenberg, 2005 .

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

G. Serratrice, D. Isenberg, J. Callen, 2004, Rheumatology.

The effect of vitamin B12 and folic acid supplementation on routine haematological parameters in older people: an individual participant data meta-analysis

T. Stijnen, A. Mangoni, L. D. de Groot, 2018, European Journal of Clinical Nutrition.

Evaluation of essential clinical components and features of current acne global grading scales.

Jerry Tan, Emily Jones, S. Pripotnev, 2013, Journal of the American Academy of Dermatology.

Development and initial validation of an updated version of the British Isles Lupus Assessment Group ’ s disease activity index for patients with systemic lupus erythematosus

D A Isenberg, I. Bruce, C. Gordon, 2005 .

An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA

I. Bruce, D. Gladman, C. Gordon, 2010, Annals of the rheumatic diseases.

A statistical analysis of the interrelationships between disease activity in different systems in systemic lupus erythematosus.

C. Gordon, D. Isenberg, V. Farewell, 2006, Rheumatology.

Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors

S. West, D. Mabey, E. Harding-Esch, 2014, PLoS neglected tropical diseases.

version of SELENA comparison of BILAG 2004 and the flare with systemic lupus erythematosus : a An assessment of disease flare in patients

I. Bruce, D. Gladman, C. Gordon, 2022 .

Interrater reliability and aspects of validity of the myositis damage index

D. Isenberg, J. Vencovský, R. Cooper, 2011, Annals of the rheumatic diseases.

Reliability and validity of the myositis disease activity assessment tool.

D. Isenberg, J. Vencovský, R. Cooper, 2008, Arthritis and rheumatism.

Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years.

D. Isenberg, Anisur Rahman, E. Allen, 2009, Rheumatology.